Prasugrel is superior to ticagrelor for reducing ischemic events in patients with acute coronary syndrome and a planned invasive strategy. The late-breaking results of the ISAR-REACT 5 trial were...
ESC
This channel contains news about the European Society of Cardiology (ESC), including coverage of its annual meeting and new guidelines. ESC is a leading resource for cardiology science and information in Europe.
-
-
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinical Trial presentations highlighting the latest cardiovascular science.
-
September 7, 2017 — Oxygen therapy does not improve survival in patients with heart attack symptoms, according to late-breaking research from the DETO2X-AMI Study presented in a Hot Line session...
-
Medtronic plc announced its intent to move forward with a new renal denervation pivotal trial following positive first results from a sham-controlled study in patients with high blood pressure....
News | Implantable Cardioverter Defibrillator (ICD) | September 18, 2019
September 18, 2019 — Early use of an...
News | Blood Testing | September 18, 2019
September 18, 2019 — Discharge of patients with suspected acute coronary syndromes under a 0- and 1-hour...
News | Heart Failure | September 18, 2019
September 18, 2019 — AstraZeneca announced the U.S. Food and Drug Administration (FDA) has granted Fast Track...
News | CT Angiography (CTA) | September 17, 2019
September 17, 2019 — The European Society of Cardiology (ESC) published new...
News | Heart Valve Technology | September 11, 2019
September 11, 2019 — Percutaneous reduction of...
Image courtesy of Amazon.com
News | Heart Failure | September 11, 2019
September 11, 2019 — The ever-present devices that seem to track all our moves can be annoying, intrusive or worse,...
News | Antiplatelet and Anticoagulation Therapies | September 10, 2019
September 10,2019 — The combination of...
News | Cath Lab | September 10, 2019
September 10, 2019 — An international randomized trial has shown that complete revascularization reduces major...
News | Antiplatelet and Anticoagulation Therapies | September 09, 2019
September 9, 2019 — Prasugrel is superior to ticagrelor for reducing ischemic events in patients with acute coronary...
ESC President Barbara Casadei, M.D., DPhil, FRCP, FESC, a British Heart Foundation Professor and an honorary consultant cardiologist at the John Radcliffe Hospital in Oxford, speaks at a press conference at the 2019 ESC Congress.
Feature | ESC | September 09, 2019
September 9, 2019 — More than 33,000 health professionals gathered over five days to attend the 2019...
News | Heart Failure | September 09, 2019
September 9, 2019 — The drug Dapagliflozin was found to reduce death and hospitalization in patients who have heart...
News | Stents Drug Eluting | September 05, 2019
September 5, 2019 — Biotronik's ultrathin Orsiro stent demonstrated superiority over Xience with respect to target...
